Valuing Mortality Risk Reductions

CHDS faculty Lisa A. Robinson and James K. Hammitt, and research staff Lucy O’Keeffe, recently published “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.”

This article is the culmination of a major effort to integrate work on valuing mortality risk reductions (commonly referred to as the value per statistical life, VSL) in low- and middle-income countries, as part of the Guidelines for Benefit-Cost Analysis project. The article is currently available on FirstView, and will be published as part of a Journal of Benefit-Cost Analysis in the forthcoming special issue on “Benefit-Cost Analysis in Low- and Middle-Income Countries: Methods and Case Studies”.

Learn more: Read about benefit cost analysis here.

Related news: Teaching Benefit-Cost Analysis
Related news: Ethics in Health Care